Literature DB >> 16765298

Lung injury from smoke inhalation.

Ada S Lee1, Robert B Mellins.   

Abstract

Significant morbidity and mortality from smoke inhalation occurs in victims of fire. Lung injury can be caused by chemical and thermal insults. A variety of noxious gases, irritants and asphyxiants are generated depending on the material burnt. Carbon monoxide is the predominant cause of death among fire victims. Treatment should be directed at reversing hypoxaemia as a result of asphyxia or carbon monoxide poisoning. There is no evidence that the routine use of corticosteroids or prophylactic antibiotics is beneficial. Through a better understanding of the pathophysiology of smoke-induced lung injury, the effects of exogenous surfactant, leukotriene inhibitors, antioxidants, nitric oxide synthase inhibitors and fibrinolytics suggest that these compounds may have a future therapeutic role in smoke-induced injury. Studies are needed to evaluate the safety and efficacy of these potential therapies before they are used clinically.

Entities:  

Mesh:

Year:  2006        PMID: 16765298     DOI: 10.1016/j.prrv.2006.03.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  9 in total

Review 1.  Expert consensus on nebulization therapy in pre-hospital and in-hospital emergency care.

Authors: 
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.

Authors:  Andrew C Miller; Elamin M Elamin; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

3.  [Burn patients and their respiration problems].

Authors:  J Fassi Fihri; M Ezzoubi; E H Boukind
Journal:  Ann Burns Fire Disasters       Date:  2010-12-31

4.  Accuracy of carboxyhemoglobin detection by pulse CO-oximetry during hypoxemia.

Authors:  John R Feiner; Mark D Rollins; Jeffrey W Sall; Helge Eilers; Paul Au; Philip E Bickler
Journal:  Anesth Analg       Date:  2013-03-11       Impact factor: 5.108

5.  Effects of simvastatin on iNOS and caspase‑3 levels and oxidative stress following smoke inhalation injury.

Authors:  Rong-Qiang Yang; Peng-Fei Guo; Zhao Ma; Cheng Chang; Qing-Nan Meng; Ya Gao; Imran Khan; Xiao-Bo Wang; Zheng-Jun Cui
Journal:  Mol Med Rep       Date:  2020-08-04       Impact factor: 2.952

6.  Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome.

Authors:  Zhao Yilin; Nan Yandong; Jin Faguang
Journal:  Burns       Date:  2015-05-14       Impact factor: 2.744

7.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

8.  Repeated Bronchoscopy - Treatment of Severe Respiratory Failure in a Fire Victim.

Authors:  Ovidiu Rusalim Petris; Cristina Bologa; Victorita Sorodoc; Catalina Lionte
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-11-08

9.  SOCS-1 Suppresses Inflammation Through Inhibition of NALP3 Inflammasome Formation in Smoke Inhalation-Induced Acute Lung Injury.

Authors:  Leifang Zhang; Chenming Xu; Xiaoming Chen; Qiwen Shi; Weike Su; Hang Zhao
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.